🇺🇸 FDA
Patent

US 12291548

Compounds, compositions, and methods for the treatment of disease

granted A61KA61K31/7084A61K45/06

Quick answer

US patent 12291548 (Compounds, compositions, and methods for the treatment of disease) held by Sperovie Biosciences, Inc. expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sperovie Biosciences, Inc.
Grant date
Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7084, A61K45/06, A61K47/549, A61K47/55